You are about to be redirected to a site intended for people with primary HLH or their caregivers.
You are being redirected to a third party website.
Sobi takes no responsibility for the content of this website.
To order Gamifant, you must submit a Start Form.
The Start Form enrolls your patient in Gamifant Patient Services and can be used to initiate insurance benefit verification, coordinate product orders through our Specialty Pharmacy or Specialty Distributor, and assess patient’s eligibility for financial assistance.
Simply download and complete the Gamifant Start Form and fax it to Gamifant Patient Services at 866.895.7204.
Once the start form has been received, a member of the Gamifant Patient Services team will contact you to facilitate the ordering process and help ensure that your patient receives their treatment as quickly as possible.
The Gamifant Patient Services team is standing by to help:
Before your patient’s first infusion, your local Sobi Health Systems Director will reach out to schedule an on-site Gamifant preparation and administration in-service program.
We understand that primary HLH requires an urgent response. That's why we're committed to doing everything we can to ensure all orders are delivered to your facility as quickly as possible.
Primary hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory condition that mostly affects children, but can also occur in adults and teenagers.1-4
Gamifant reduces the inflammatory symptoms of primary HLH by neutralizing IFNγ.5
Gamifant is given as an intravenous infusion twice a week until hematopoietic stem cell transplantation (HSCT) is performed.5
Download the Start Form now or contact Gamifant Patient Services at 833.597.6530.